Cancer

• 

  Publication Venue For

  • Association of area-level socioeconomic status and non-small cell lung cancer stage by race/ethnicity and health care-level factors: Analysis of the National Cancer Database. 2022
  • Evolving strategies for management of desmoid tumor. 2022
  • Setting a new standard for long-term survival in metastatic kidney cancer..  128:2058-2060. 2022
  • "Is it cancer or not?" A qualitative exploration of survivor concerns surrounding the diagnosis and treatment of ductal carcinoma in situ..  128:1676-1683. 2022
  • Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study..  128:1194-1205. 2022
  • Psychosocial factors associated with genetic testing status among African American women with ovarian cancer: Results from the African American Cancer Epidemiology Study..  128:1252-1259. 2022
  • Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920..  128:966-974. 2022
  • Risk of suicide among individuals with a history of childhood cancer..  128:624-632. 2022
  • Do you mind if I record?: Perceptions and practice regarding patient requests to record clinic visits in oncology..  128:275-283. 2022
  • Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor..  128:373-382. 2022
  • Social determinants of health and cancer mortality in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study..  128:122-130. 2022
  • The importance of the person/patient/survivor's lived experience across the cancer control continuum..  128:34-38. 2022
  • Palliative care and coping in patients with acute myeloid leukemia: Mediation analysis of data from a randomized clinical trial..  127:4702-4710. 2021
  • Clinical and genetic risk factors for radiation-associated ototoxicity: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort..  127:4091-4102. 2021
  • The impact of the social construct of race on outcomes among bacille Calmette-Guérin-treated patients with high-risk non-muscle-invasive bladder cancer in an equal-access setting..  127:3998-4005. 2021
  • Patients, caregivers, and clinicians differ in performance status ratings: Implications for pediatric cancer clinical trials..  127:3664-3670. 2021
  • Material, behavioral, and psychological financial hardship among survivors of childhood cancer in the Childhood Cancer Survivor Study..  127:3214-3222. 2021
  • A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer..  127:2954-2965. 2021
  • Electronic symptom monitoring in pediatric patients hospitalized for chemotherapy..  127:2980-2989. 2021
  • Posttraumatic stress disorder symptoms in patients with acute myeloid leukemia..  127:2500-2506. 2021
  • Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC)..  127:2204-2212. 2021
  • Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2)..  127:2251-2261. 2021
  • Systematic review of financial burden assessment in cancer: Evaluation of measures and utility among adolescents and young adults and caregivers..  127:1739-1748. 2021
  • Reply to the Importance of a collaborative health-related quality of life measurement strategy for adolescents and young adults with cancer..  127:1714-1715. 2021
  • Validation of the caregiver Pediatric Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events measure..  127:1483-1494. 2021
  • Patient-reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancer..  127:957-967. 2021
  • Patient-reported causes of distress predict disparities in time to evaluation and time to treatment after breast cancer diagnosis..  127:757-768. 2021
  • The cost-effectiveness of treating childhood cancer in 4 centers across sub-Saharan Africa..  127:787-793. 2021
  • The mutational landscape of early- and typical-onset oral tongue squamous cell carcinoma..  127:544-553. 2021
  • Reconciling outcomes for Black men with prostate cancer within and outside the Veterans Health Administration..  127:342-344. 2021
  • Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children's Oncology Group..  127:275-283. 2021
  • Genetic variation in the body mass index of adult survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort..  127:310-318. 2021
  • Impact of adjuvant trastuzumab on locoregional failure rates in a randomized clinical trial: North Central Cancer Treatment Group N9831 (alliance) study..  126:5239-5246. 2020
  • Quality-adjusted survival with first-line cabozantinib or sunitinib for advanced renal cell carcinoma in the CABOSUN randomized clinical trial (Alliance)..  126:5311-5318. 2020
  • Trends in screening breast magnetic resonance imaging use among US women, 2006 to 2016..  126:5293-5302. 2020
  • Time-varying survival effects for squamous cell carcinomas at oropharyngeal and nonoropharyngeal head and neck sites in the United States, 1973-2015..  126:5137-5146. 2020
  • Optimizing the measurement of health-related quality of life in adolescents and young adults with cancer..  126:4818-4824. 2020
  • A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer..  126:4485-4497. 2020
  • Association between race and treatment patterns and survival outcomes in multiple myeloma: A Connect MM Registry analysis..  126:4332-4340. 2020
  • A multi-institutional phase 2 trial of regorafenib in refractory advanced biliary tract cancer..  126:3464-3470. 2020
  • Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma..  126:3493-3503. 2020
  • Importance of quality-of-life priorities and preferences surrounding treatment decision making in patients with cancer and oncology clinicians..  126:3534-3541. 2020
  • Congruence of patient- and clinician-reported toxicity in women receiving chemotherapy for early breast cancer..  126:3084-3093. 2020
  • Impact of the Patient Protection and Affordable Care Act on cost-related medication underuse in nonelderly adult cancer survivors..  126:2892-2899. 2020
  • Longitudinal pain and pain interference in long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study..  126:2915-2923. 2020
  • Mind the gap: Gendered publication trends in oncology..  126:2859-2865. 2020
  • Reply to Potential underestimation of cerebrovascular events in the PROVENGE Registry for the Observation, Collection, and Evaluation of Experience Data..  126:2935-2937. 2020
  • Prevalence of decisional regret among patients who underwent allogeneic hematopoietic stem cell transplantation and associations with quality of life and clinical outcomes..  126:2679-2686. 2020
  • The Chicago Consensus on peritoneal surface malignancies: Management of appendiceal neoplasms..  126:2525-2533. 2020
  • The Chicago Consensus on peritoneal surface malignancies: Management of colorectal metastases..  126:2534-2540. 2020
  • The Chicago Consensus on peritoneal surface malignancies: Management of desmoplastic small round cell tumor, breast, and gastrointestinal stromal tumors..  126:2566-2570. 2020
  • The Chicago Consensus on peritoneal surface malignancies: Management of gastric metastases..  126:2541-2546. 2020
  • The Chicago Consensus on peritoneal surface malignancies: Management of neuroendocrine tumors..  126:2561-2565. 2020
  • The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms..  126:2553-2560. 2020
  • The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma..  126:2547-2552. 2020
  • The Chicago Consensus on peritoneal surface malignancies: Palliative care considerations..  126:2571-2576. 2020
  • The Chicago Consensus on peritoneal surface malignancies: Standards..  126:2516-2524. 2020
  • Clustering of cutaneous T-cell lymphoma is associated with increased levels of the environmental toxins benzene and trichloroethylene in the state of Georgia..  126:1700-1707. 2020
  • Current multidisciplinary management of brain metastases..  126:1390-1406. 2020
  • Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors..  126:1208-1216. 2020
  • Patient-hematologist discordance in perceived chance of cure in hematologic malignancies: A multicenter study..  126:1306-1314. 2020
  • Factors associated with biomedical research participation within community-based samples across 3 National Cancer Institute-designated cancer centers..  126:1077-1089. 2020
  • Patient-reported outcomes in the Translational Breast Cancer Research Consortium..  126:922-930. 2020
  • Rising incidence of late-stage head and neck cancer in the United States..  126:1090-1101. 2020
  • Stroke impact on mortality and psychologic morbidity within the Childhood Cancer Survivor Study..  126:1051-1059. 2020
  • Barriers and facilitators of risk-based health care for adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study..  126:619-627. 2020
  • The impact of the Patient Protection and Affordable Care Act on insurance coverage and cancer-directed treatment in HIV-infected patients with cancer in the United States..  126:559-566. 2020
  • Findings from the National Navigation Roundtable: A call for competency-based patient navigation training..  125:4350-4359. 2019
  • Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancer..  125:4399-4406. 2019
  • Perceived discrimination, trust in physicians, and prolonged symptom duration before ovarian cancer diagnosis in the African American Cancer Epidemiology Study..  125:4442-4451. 2019
  • Association of neurologic deficits with surgical outcomes and health-related quality of life after treatment for metastatic epidural spinal cord compression..  125:4224-4231. 2019
  • Effects of cancer history on functional age and mortality..  125:4303-4309. 2019
  • Proton-beam therapy after radical prostatectomy: Continued DVH idolatry?.  125:4136-4138. 2019
  • Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancer..  125:4172-4180. 2019
  • The association of pharmacy fill synchronization with breast cancer endocrine therapy adherence..  125:3960-3965. 2019
  • Late-onset anorectal disease and psychosocial impact in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study..  125:3873-3881. 2019
  • Glioma incidence and survival variations by county-level socioeconomic measures..  125:3390-3400. 2019
  • Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high-risk follicular lymphoma: CALGB 50904 (Alliance)..  125:3378-3389. 2019
  • Reflecting on survivorship outcomes to aid initial decision making in patients treated for IDH-mutated anaplastic glioma..  125:3457-3466. 2019
  • Increased local failure for patients with intermediate-risk rhabdomyosarcoma on ARST0531: A report from the Children's Oncology Group..  125:3242-3248. 2019
  • Impact of exercise on psychological burden in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study..  125:3059-3067. 2019
  • Influence of African American race on the association between preoperative biopsy grade group and adverse histopathologic features of radical prostatectomy..  125:3025-3032. 2019
  • Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practice..  125:2945-2954. 2019
  • The effect of treatment on patient-reported distress after breast cancer diagnosis..  125:3040-3049. 2019
  • A phase 1 trial of the oral DNA methyltransferase inhibitor CC-486 and the histone deacetylase inhibitor romidepsin in advanced solid tumors..  125:2837-2845. 2019
  • Survival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity-scored analysis of the National Cancer Data Base..  125:2782-2793. 2019
  • Role of pelvic chemoradiation therapy in patients with initially metastatic anal canal cancer: A National Cancer Database review..  125:2115-2122. 2019
  • Breast cancer deaths averted over 3 decades..  125:1482-1488. 2019
  • Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer..  125:1459-1469. 2019
  • A phase 1 trial of SGN-CD70A in patients with CD70-positive, metastatic renal cell carcinoma..  125:1124-1132. 2019
  • A phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma..  125:1113-1123. 2019
  • Cancer disparities in people with HIV: A systematic review of screening for non-AIDS-defining malignancies..  125:843-853. 2019
  • Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations..  125:575-585. 2019
  • A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patients..  125:382-390. 2019
  • Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials..  125:18-44. 2019
  • Place of death for patients with cancer in the United States, 1999 through 2015: Racial, age, and geographic disparities..  124:4408-4419. 2018
  • Suicide risk among cancer survivors: Head and neck versus other cancers..  124:4072-4079. 2018
  • Rationale and emerging strategies for immune checkpoint blockade in soft tissue sarcoma..  124:3819-3829. 2018
  • Genetic determinants of childhood and adult height associated with osteosarcoma risk..  124:3742-3752. 2018
  • The role of external beam radiotherapy in the treatment of hepatocellular cancer..  124:3476-3489. 2018
  • A home-based mentored vegetable gardening intervention demonstrates feasibility and improvements in physical activity and performance among breast cancer survivors..  124:3427-3435. 2018
  • Association between patient-reported hearing and visual impairments and functional, psychological, and cognitive status among older adults with cancer..  124:3249-3256. 2018
  • Long-term psychological and educational outcomes for survivors of neuroblastoma: A report from the Childhood Cancer Survivor Study..  124:3220-3230. 2018
  • Quality of life as a prognostic indicator of survival: A pooled analysis of individual patient data from canadian cancer trials group clinical trials..  124:3409-3416. 2018
  • Symptom and function profiles of men with localized prostate cancer..  124:2832-2840. 2018
  • Feasibility, safety, and efficacy of aerobic training in pretreated patients with metastatic breast cancer: A randomized controlled trial..  124:2552-2560. 2018
  • Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA..  124:2115-2124. 2018
  • Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer..  124:1904-1911. 2018
  • Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review..  124:667-678. 2018
  • Cancer cachexia: Are we ready to take a step forward?.  124:456-458. 2018
  • Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report..  124:617-625. 2018
  • Trends and variations in postmastectomy radiation therapy for breast cancer in patients with 1 to 3 positive lymph nodes: A National Cancer Data Base analysis..  124:482-490. 2018
  • Quality of life after surgery for intracranial meningioma..  124:161-166. 2018
  • Survival of human papillomavirus-associated cancers: Filling in the gaps..  124:18-20. 2018
  • Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer..  123:4886-4894. 2017
  • Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful..  123:4687-4700. 2017
  • Comparative "nocebo effects" in older patients enrolled in cancer therapeutic trials: Observations from a 446-patient cohort..  123:4193-4198. 2017
  • Understanding the relationship between the Centers for Medicare and Medicaid Services' Hospital Compare star rating, surgical case volume, and short-term outcomes after major cancer surgery..  123:4259-4267. 2017
  • Validation of the 2015 prostate cancer grade groups for predicting long-term oncologic outcomes in a shared equal-access health system..  123:4122-4129. 2017
  • Germline genetic variants in men with prostate cancer and one or more additional cancers..  123:3925-3932. 2017
  • Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients..  123:4004-4012. 2017
  • Reply to Second malignancies in Ewing sarcoma survivors..  123:4075-4076. 2017
  • Exploiting DNA damage without repair: The activity of platinum chemotherapy in BRCA-mutated prostate cancers..  123:3441-3444. 2017
  • Supporting cancer family caregivers: How can frontline oncology clinicians help?.  123:3212-3215. 2017
  • Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study..  123:2551-2560. 2017
  • Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials..  123:2472-2481. 2017
  • Clinical outcomes and survival surrogacy studies of prostate-specific antigen declines following enzalutamide in men with metastatic castration-resistant prostate cancer previously treated with docetaxel..  123:2303-2311. 2017
  • What do these scores mean? Presenting patient-reported outcomes data to patients and clinicians to improve interpretability..  123:1848-1859. 2017
  • Total neoadjuvant therapy for rectal cancer: An emerging option..  123:1497-1506. 2017
  • Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States..  123:1434-1441. 2017
  • Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting..  123:1259-1271. 2017
  • Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study..  123:1144-1155. 2017
  • Immunotherapy approaches in the treatment of malignant brain tumors..  123:734-750. 2017
  • Mutation location on the RAS oncogene affects pathologic features and survival after resection of colorectal liver metastases..  123:568-575. 2017
  • Impact of chronic disease on emotional distress in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study..  123:521-528. 2017
  • Screening for depression in cancer patients receiving radiotherapy: Feasibility and identification of effective tools in the NRG Oncology RTOG 0841 trial..  123:485-493. 2017
  • Relation of comorbidities and patient navigation with the time to diagnostic resolution after abnormal cancer screening..  123:312-318. 2017
  • Frailty as determined by a comprehensive geriatric assessment-derived deficit-accumulation index in older patients with cancer who receive chemotherapy..  122:3865-3872. 2016
  • Risk and impact of pulmonary complications in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study..  122:3687-3696. 2016
  • Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance)..  122:3555-3563. 2016
  • The efficacy of anti-PD-1 agents in acral and mucosal melanoma..  122:3354-3362. 2016
  • Patterns and predictors of clustered risky health behaviors among adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study..  122:2747-2756. 2016
  • Improving the quality of survivorship for older adults with cancer..  122:2459-2568. 2016
  • Childhood cancer survivorship research in minority populations: A position paper from the Childhood Cancer Survivor Study..  122:2426-2439. 2016
  • Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT)..  122:2242-2250. 2016
  • Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer..  122:2091-2100. 2016
  • Is it my cancer or am i just getting older?: Impact of cancer on age-related health conditions of older cancer survivors..  122:1946-1953. 2016
  • Irradiation and immunotherapy: From concept to the clinic..  122:1659-1671. 2016
  • Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies..  122:884-892. 2016
  • Chronic medical conditions in adult survivors of retinoblastoma: Results of the Retinoblastoma Survivor Study..  122:773-781. 2016
  • Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone..  122:758-765. 2016
  • Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas..  122:582-587. 2016
  • Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies..  122:249-257. 2016
  • Concept-elicitation phase for the development of the pediatric patient-reported outcome version of the Common Terminology Criteria for Adverse Events..  122:141-148. 2016
  • Nonoperative management of rectal cancer..  122:34-41. 2016
  • Group trajectory analysis helps to identify older cancer survivors who benefit from distance-based lifestyle interventions..  121:4433-4440. 2015
  • Specialty care for adult survivors of childhood cancer..  121:4279-4281. 2015
  • Barriers to health care contribute to delays in follow-up among women with abnormal cancer screening: Data from the Patient Navigation Research Program..  121:4016-4024. 2015
  • Impact of patient navigation in eliminating economic disparities in cancer care..  121:4025-4034. 2015
  • Longitudinal smoking patterns in survivors of childhood cancer: An update from the Childhood Cancer Survivor Study..  121:4035-4043. 2015
  • Reflections from a chair: Leadership of a clinical department at an academic medical center..  121:3795-3798. 2015
  • Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer..  121:3455-3464. 2015
  • Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases..  121:3240-3251. 2015
  • Health care utilization and end-of-life care for older patients with acute myeloid leukemia..  121:2840-2848. 2015
  • Effect of age on the efficacy of adjuvant chemotherapy for resected non-small cell lung cancer..  121:2578-2585. 2015
  • Seduced by technology?.  121:2300-2302. 2015
  • Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis..  121:2164-2174. 2015
  • Patient characteristics associated with the level of patient-reported care coordination among male patients with colorectal cancer in the Veterans Affairs health care system..  121:2207-2213. 2015
  • Predictors of colorectal cancer surveillance among survivors of childhood cancer treated with radiation: a report from the Childhood Cancer Survivor Study..  121:1856-1863. 2015
  • Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint?.  121:1906. 2015
  • Reply to progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint?.  121:1906-1907. 2015
  • Teenage acne and cancer risk in US women: A prospective cohort study..  121:1681-1687. 2015
  • Clinical outcomes of patients with advanced gastrointestinal stromal tumors: safety and efficacy in a worldwide treatment-use trial of sunitinib..  121:1405-1413. 2015
  • The effects of cancer and racial disparities in health-related quality of life among older Americans: a case-control, population-based study..  121:1312-1320. 2015
  • Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration-resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance)..  121:1025-1031. 2015
  • Summing it up: an integrative review of studies of cancer survivorship care plans (2006-2013)..  121:978-996. 2015
  • Impact of colorectal cancer diagnosis and treatment on health-related quality of life among older Americans: a population-based, case-control study..  121:943-950. 2015
  • Patterns of locoregional treatment for nonmetastatic breast cancer by patient and health system factors..  121:790-799. 2015
  • Smoking history predicts for increased risk of second primary lung cancer: a comprehensive analysis..  121:598-604. 2015
  • Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000 to 2010..  121:102-112. 2015
  • Hereditary link: scientists seek clues in genetic risks for prostate cancer..  120:3847-3848. 2014
  • KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases..  120:3965-3971. 2014
  • Patient preferences in advanced or recurrent ovarian cancer..  120:3651-3659. 2014
  • Oncolytic polio virotherapy of cancer..  120:3277-3286. 2014
  • The effect of the setting of a positive surgical margin in soft tissue sarcoma..  120:2866-2875. 2014
  • Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort study..  120:2735-2741. 2014
  • Daughters and Mothers Against Breast Cancer (DAMES): main outcomes of a randomized controlled trial of weight loss in overweight mothers with breast cancer and their overweight daughters..  120:2522-2534. 2014
  • Patterns of recurrence after trimodality therapy for esophageal cancer..  120:2099-2105. 2014
  • Use and impact of adjuvant chemotherapy in patients with resected non-small cell lung cancer..  120:1939-1947. 2014
  • Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program..  120:1818-1829. 2014
  • Quality of life changes during the pre- to postdiagnosis period and treatment-related recovery time in older women with breast cancer..  120:1881-1889. 2014
  • The impact of pathologic staging on the long-term oncologic outcomes of patients with clinically high-risk prostate cancer..  120:1656-1662. 2014
  • Causes of death in long-term survivors of head and neck cancer..  120:1507-1513. 2014
  • Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808..  120:1010-1017. 2014
  • Stereotactic body radiotherapy: a critical review for nonradiation oncologists..  120:942-954. 2014
  • Survivorship care plans: is there buy-in from community oncology providers?.  120:722-730. 2014
  • Costs and outcomes evaluation of patient navigation after abnormal cancer screening: evidence from the Patient Navigation Research Program..  120:570-578. 2014
  • Involvement and targeted intervention of dysregulated Hedgehog signaling in osteosarcoma..  120:537-547. 2014
  • A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites..  120:302-311. 2014
  • Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma..  120:52-60. 2014
  • A NEIL1 single nucleotide polymorphism (rs4462560) predicts the risk of radiation-induced toxicities in esophageal cancer patients treated with definitive radiotherapy..  119:4205-4211. 2013
  • Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010..  119:4196-4204. 2013
  • A phase 2 trial of extended induction epratuzumab and rituximab for previously untreated follicular lymphoma: CALGB 50701..  119:3797-3804. 2013
  • Cost effectiveness of alternative strategies for incorporating bevacizumab into the primary treatment of ovarian cancer..  119:3653-3661. 2013
  • Pharmacogenetic testing in the face of unclear clinical efficacy: lessons from cytochrome P450 2D6 for tamoxifen..  119:3703-3709. 2013
  • The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance)..  119:3636-3643. 2013
  • Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma..  119:3334-3342. 2013
  • Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers..  119:2593-2601. 2013
  • Heart rate decrease during crizotinib treatment and potential correlation to clinical response..  119:1969-1975. 2013
  • Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017..  119:1776-1783. 2013
  • A Web-based communication aid for patients with cancer: the CONNECT Study..  119:1437-1445. 2013
  • Predictors of smoking relapse in patients with thoracic cancer or head and neck cancer..  119:1420-1427. 2013
  • Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer..  119:1344-1348. 2013
  • Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status..  119:1402-1411. 2013
  • Treatment of adults with acute lymphoblastic leukemia: do the specifics of the regimen matter?: Results from a prospective randomized trial..  119:1186-1194. 2013
  • Chemotherapy use and patient treatment preferences in advanced colorectal cancer: a prospective cohort study..  119:854-862. 2013
  • A multi-institution experience comparing the clinical and physiologic differences between upper extremity and lower extremity melphalan-based isolated limb infusion..  118:6136-6143. 2012
  • Cost effectiveness of gene expression profiling for early stage breast cancer: a decision-analytic model..  118:6298-6299. 2012
  • Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators..  118:5749-5756. 2012
  • Impact of diagnosis and treatment of clinically localized prostate cancer on health-related quality of life for older Americans: a population-based study..  118:5679-5687. 2012
  • Phase 3, randomized, placebo-controlled study of zibotentan (ZD4054) in patients with castration-resistant prostate cancer metastatic to bone..  118:5709-5718. 2012
  • Primary care providers' perspectives on discontinuing prostate cancer screening..  118:5518-5524. 2012
  • Intraoperative detection and removal of microscopic residual sarcoma using wide-field imaging..  118:5320-5330. 2012
  • Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer..  118:5414-5423. 2012
  • Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1..  118:5171-5178. 2012
  • Neighborhood-level socioeconomic determinants impact outcomes in nonsmall cell lung cancer patients in the Southeastern United States..  118:5117-5123. 2012
  • Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma..  118:4759-4767. 2012
  • The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases..  118:4737-4747. 2012
  • Dental x-rays and risk of meningioma..  118:4530-4537. 2012
  • Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis..  118:4309-4320. 2012
  • Descriptive epidemiology of malignant and nonmalignant primary spinal cord, spinal meninges, and cauda equina tumors, United States, 2004-2007..  118:4220-4227. 2012
  • Efficacy of peripheral androgen blockade in prostate cancer patients with biochemical failure after definitive local therapy: results of Cancer and Leukemia Group B (CALGB) 9782..  118:4139-4147. 2012
  • Radiation therapy at the end of life in patients with incurable nonsmall cell lung cancer..  118:4339-4345. 2012
  • Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation..  118:3801-3811. 2012
  • Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era..  118:3571-3578. 2012
  • Predicting toxicity from radiation therapy--it's genetic, right?.  118:3450-3454. 2012
  • A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer..  118:3283-3293. 2012
  • Insular thyroid cancer: a population-level analysis of patient characteristics and predictors of survival..  118:3260-3267. 2012
  • Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score..  118:3377-3386. 2012
  • Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma..  118:3311-3320. 2012
  • Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome..  118:3182-3190. 2012
  • Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease..  118:2962-2970. 2012
  • Comparison of the use and results of sentinel lymph node biopsy in children and young adults with melanoma..  118:2700-2707. 2012
  • A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma..  118:2069-2077. 2012
  • Modifying effect of MDM4 variants on risk of HPV16-associated squamous cell carcinoma of oropharynx..  118:1684-1692. 2012
  • Systemic therapy for advanced soft tissue sarcomas: highlighting novel therapies and treatment approaches..  118:1474-1485. 2012
  • Bevacizumab and daily temozolomide for recurrent glioblastoma..  118:1302-1312. 2012
  • Family history of cancer and risk of sporadic differentiated thyroid carcinoma..  118:1228-1235. 2012
  • Medullary thyroid microcarcinoma: a population-level analysis of 310 patients..  118:620-627. 2012
  • Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancer..  118:386-391. 2012
  • Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in nonsmall cell lung cancer patients treated with definitive radiotherapy..  118:528-535. 2012
  • Genetic variants of the p53 and p73 genes jointly increase risk of second primary malignancies in patients after index squamous cell carcinoma of the head and neck..  118:485-492. 2012
  • Identification of potential prognostic biomarkers in patients with untreated, advanced pancreatic cancer from a phase 3 trial (Cancer and Leukemia Group B 80303)..  118:571-578. 2012
  • Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 study..  118:63-71. 2012
  • Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation..  118:268-277. 2012
  • Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: long-term results of CALGB 99809..  117:5579-5588. 2011
  • Human papillomavirus vaccine uptake among 9- to 17-year-old girls: National Health Interview Survey, 2008..  117:5612-5620. 2011
  • Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy..  117:5351-5358. 2011
  • Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation..  117:4671-4678. 2011
  • Age-related disparities in the use of radiotherapy for treatment of localized soft tissue sarcoma..  117:4033-4040. 2011
  • Salvage radiation in men after prostate-specific antigen failure and the risk of death..  117:3925-3932. 2011
  • The association between radiographic response and overall survival in men with metastatic castration-resistant prostate cancer receiving chemotherapy..  117:3963-3971. 2011
  • Having health insurance does not eliminate race/ethnicity-associated delays in breast cancer diagnosis in the District of Columbia..  117:3824-3832. 2011
  • Survivorship navigation outcome measures: a report from the ACS patient navigation working group on survivorship navigation..  117:3575-3584. 2011
  • Occupational outcomes of adult childhood cancer survivors: A report from the childhood cancer survivor study..  117:3033-3044. 2011
  • A phase 2 trial of gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma : cancer and Leukemia Group B (CALGB) 80003..  117:2620-2628. 2011
  • Studying cancer in minorities: a look at the numbers..  117:2762-2769. 2011
  • V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials..  117:2478-2488. 2011
  • Re: Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer..  112:2518-2519. 2008
  • Disease characteristics and mortality among Asian women with breast cancer. 2022
  • Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program: A retrospective review of 90,000 women. 2021
  • Mapping child and adolescent self-reported symptom data to clinician-reported adverse event grading to improve pediatric oncology care and research. 2020
  • What do transplant physicians think about palliative care? A national survey study. 2018
  • Preoperative experience for public hospital patients with gynecologic cancer: Do structural barriers widen the gap? 2016
  • The use of adjuvant radiotherapy in elderly patients with early-stage breast cancer: changes in practice patterns after publication of Cancer and Leukemia Group B 9343. 2015
  • Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022). 2013
  • Long-term cardiac safety and outcomes of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer. 2013